Official Title
EpidemiologiCal POpulatioN STudy of SARS-CoV-2 in Lake CounTy, Illinois: CONTACT
Brief Summary

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Lung failure is the main cause of death related to COVID-19 infection. The main objective of this study is to assess infection of SARS-CoV-2 and how quality of life is affected in adult volunteers in Lake County, Illinois. Volunteers will be recruited through digital advertisements and participants will be required to fill an online questionnaire. Upon consent, participants will be required to provide nasal swab and blood sample. Approximately 1250 adult volunteers living or working in Lake County, IL will be enrolled. Participants will be followed for approximately 9 months and will be required to provide nasal swab and blood samples every 3 months and complete questionnaires every 2 weeks. There may be higher treatment burden for participants in this trial. Participants will be monitored by medical assessments, blood tests and questionnaires.

Completed
Severe Acute Respiratory Syndrome - CoronaVirus 2 (SARS-CoV-2)
Eligibility Criteria

Inclusion Criteria:

- Currently living or employed in Lake County, Illinois.

- Have regular access to computer, smartphone or tablet and sufficient internet access
to connect to study platform.

- Willing and able to provide informed consent for collection of online data and of
respiratory and blood specimens.

- Willing and able to follow the procedures of the study.

- Able to complete survey in English or Spanish.

Exclusion Criteria:

- Unable to provide informed consent.

- Unable to perform the requested study tasks and unable or unwilling to assign a proxy
informant to complete the tasks.

- Hospitalized at the time of study enrollment.

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
United States
Locations

Great Lakes Clinical Trials /ID# 224874
Chicago, Illinois, United States

ABBVIE INC., Study Director
AbbVie

NCT Number
Keywords
Severe acute respiratory syndrome - coronavirus 2
SARS-CoV-2
Coronavirus disease 2019
Covid-19
MeSH Terms
Coronavirus Infections
Severe Acute Respiratory Syndrome
Syndrome